表紙
市場調査レポート

Asklepios BioPharmaceutical, Inc.:製品パイプライン分析

Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 257900
出版日 ページ情報 英文 23 Pages
即納可能
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。
Back to Top
Asklepios BioPharmaceutical, Inc.:製品パイプライン分析 Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2015
出版日: 2015年05月20日 ページ情報: 英文 23 Pages
概要

Asklepios BioPharmaceutical, Inc. は米国に本社を置くバイオテクノロジー企業です。新規タンパク質および細胞性医薬品の開発・提供を行っています。筋ジストロフィー、B型血友病、鬱血性心不全、てんかん、A型血友病、網膜色素変性症、変形性関節症などの治療薬をBNPという遺伝子デリバリーの技術プラットフォームを利用して開発しています。

当レポートでは、Asklepios BioPharmaceutical, Inc. における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

目次

Asklepios BioPharmaceutical, Inc. の基本情報

  • Asklepios BioPharmaceutical, Inc. の概要
  • 主要情報
  • 企業情報

Asklepios BioPharmaceutical, Inc. :R&Dの概要

  • 主な治療範囲

Asklepios BioPharmaceutical, Inc. :パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

Asklepios BioPharmaceutical, Inc. :パイプライン製品の概況

  • 臨床段階にあるパイプライン製品
    • 第?相の製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 前臨床段階の製品/併用療法モダリティ
    • 創薬段階の製品/併用療法モダリティ

Asklepios BioPharmaceutical, Inc. :薬剤プロファイル

  • Biostrophin
  • BNP-CHF
  • BNP-TLE
  • BNP-OA
  • BNP-RP

Asklepios BioPharmaceutical, Inc. :パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

Asklepios BioPharmaceutical, Inc. :最新のパイプライン情報

Asklepios BioPharmaceutical, Inc. :本社と子会社の所在地

  • 本社

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07065CDB

Summary

Global Markets Direct's, 'Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2015', provides an overview of the Asklepios BioPharmaceutical, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Asklepios BioPharmaceutical, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Asklepios BioPharmaceutical, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Asklepios BioPharmaceutical, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Asklepios BioPharmaceutical, Inc.'s pipeline products

Reasons to buy

  • Evaluate Asklepios BioPharmaceutical, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Asklepios BioPharmaceutical, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Asklepios BioPharmaceutical, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Asklepios BioPharmaceutical, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Asklepios BioPharmaceutical, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Asklepios BioPharmaceutical, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Asklepios BioPharmaceutical, Inc. Snapshot
    • Asklepios BioPharmaceutical, Inc. Overview
    • Key Information
    • Key Facts
  • Asklepios BioPharmaceutical, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Asklepios BioPharmaceutical, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Asklepios BioPharmaceutical, Inc. - Pipeline Products Glance
    • Asklepios BioPharmaceutical, Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Asklepios BioPharmaceutical, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Asklepios BioPharmaceutical, Inc. - Drug Profiles
    • Biostrophin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BNP-CHF
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BNP-TLE
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BNP-OA
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BNP-RP
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Asklepios BioPharmaceutical, Inc. - Pipeline Analysis
  • Asklepios BioPharmaceutical, Inc. - Pipeline Products by Target
  • Asklepios BioPharmaceutical, Inc. - Pipeline Products by Route of Administration
  • Asklepios BioPharmaceutical, Inc. - Pipeline Products by Molecule Type
  • Asklepios BioPharmaceutical, Inc. - Pipeline Products by Mechanism of Action
  • Asklepios BioPharmaceutical, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Asklepios BioPharmaceutical, Inc., Key Information
  • Asklepios BioPharmaceutical, Inc., Key Facts
  • Asklepios BioPharmaceutical, Inc. - Pipeline by Indication, 2015
  • Asklepios BioPharmaceutical, Inc. - Pipeline by Stage of Development, 2015
  • Asklepios BioPharmaceutical, Inc. - Monotherapy Products in Pipeline, 2015
  • Asklepios BioPharmaceutical, Inc. - Phase I, 2015
  • Asklepios BioPharmaceutical, Inc. - Preclinical, 2015
  • Asklepios BioPharmaceutical, Inc. - Discovery, 2015
  • Asklepios BioPharmaceutical, Inc. - Pipeline by Target, 2015
  • Asklepios BioPharmaceutical, Inc. - Pipeline by Route of Administration, 2015
  • Asklepios BioPharmaceutical, Inc. - Pipeline by Molecule Type, 2015
  • Asklepios BioPharmaceutical, Inc. - Pipeline Products by Mechanism of Action, 2015

List of Figures

  • Asklepios BioPharmaceutical, Inc. - Pipeline by Top 10 Indication, 2015
  • Asklepios BioPharmaceutical, Inc. - Pipeline by Stage of Development, 2015
  • Asklepios BioPharmaceutical, Inc. - Monotherapy Products in Pipeline, 2015
  • Asklepios BioPharmaceutical, Inc. - Pipeline by Top 10 Molecule Type, 2015
Back to Top